Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Fitish vs Rixa Health

Fitish
Graded #235

Higher grade

vs+4.200000000000003
Rixa Health
Graded #320

Lower grade

The verdict

Fitish takes it — 64.7/100 to 60.5/100.

Fitish grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Fitish offers compounded semaglutide ($219/28 days) and compounded tirzepatide ($339/28 days) including consultation and shipping.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFitish +6
51
45
Dose & formulationFitish +24
75
51
Clinical oversightRixa Health +11
74
85
Labs & monitoringRixa Health +11
52
63
FulfillmentFitish +5
83
78
Contract termsFitish +14
55
41
Fitish · left barRixa Health · right bar

The numbers

MetricFitishRixa Health
WeighScore64.7/10060.5/100
GradeCC
Scorecard rank#235#320
Semaglutide$219/mo (compounded)Not disclosed
Tirzepatide$339/mo (compounded)Not disclosed
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Fitish

Graded #235 · C

Strengths

  • LegitScript certified
  • Ships to all US states
  • Price includes consult, shipping, and medication
  • Injectable and oral tablet formats
  • Microdosing option available

Where it loses points

  • No physical address disclosed
  • Broader wellness/beauty brand — GLP-1 is one product line
  • Compounded only — no brand-name options
Rixa Health

Graded #320 · C

Strengths

  • Functional-medicine, root-cause clinical approach
  • Compounded and oral semaglutide plus tirzepatide offered
  • Board-certified DO and FNP providers with years of experience
  • Medication bundled with visits into a single price
  • No charge until after approval

Where it loses points

  • No public monthly pricing; quoted only during consultation
  • Relies on compounded GLP-1, which is not FDA-approved as a finished drug
  • A handful of states still listed as coming soon
  • Branded GLP-1 medications are not the primary offering
  • Requires ongoing monthly follow-up commitment

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard